ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805851/0/en/ImmuCell-Announces-Preliminary-Unaudited-Sales-Results-for-Q4-2023.html

PORTLAND, Maine, Jan. 08, 2024 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales results for the fourth quarter of 2023, which ended December 31, 2023.

Read more at globenewswire.com

Related news for (ICCC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.